Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
Status: | Completed |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | February 2012 |
End Date: | June 2013 |
This will be a randomized, double-blind, crossover pilot study to measure the safety and
feasibility of Interleukin-1 (IL-1) blockade with Anakinra in patients with stable heart
failure with preserved ejection fraction.
feasibility of Interleukin-1 (IL-1) blockade with Anakinra in patients with stable heart
failure with preserved ejection fraction.
Inclusion Criteria:
- Symptoms and signs of congestive heart failure
- Recent Imaging Study (<12 months) showing Left Ventricular Ejection Fraction (LVEF)
>50% and Left Ventricular End Diastolic Volume Index (LVEDVI) <97ml/m2
- Evidence of abnormal Left Ventricular (LV) relaxation, filling, diastolic
distensibility, and diastolic stiffness as shown by one of the following:
1. Invasive Hemodynamic measurements
- mean Pulmonary Capillary Wedge pressure (mPCW) >12
- Left Ventricular End Diastolic Pressure (LVEDP) >16 mmHg
2. Tissue Doppler Echocardiogram
- E/E' >15
- E/E' 8-15 and one of the following
- Left Ventricular Hypertrophy (LVH)
- Atrial Fibrillation
- Left Atrial Enlargement
- E/A <0.5 + Deceleration Time (DT) >280 (if >50yrs of age)
3. Biomarkers
- Brain Natriuretic Peptide (BNP) >200pg/mL
Exclusion Criteria:
- Age <18
- Recent changes (previous 3 months) in HF maintenance medications (beta-blockers,
angiotensin converting enzyme [ACE] inhibitors, aldosterone antagonists,
vasodilators, cardiac glycosides, diuretics)
- Hospitalization for worsening Heart Failure (HF) or acute decompensated HF within the
previous 12months
- Anticipated need for cardiac resynchronization therapy (CRT) or automated-implantable
cardioverter defibrillator (AICD)
- Angina or electrocardiograph (ECG) changes that limit maximum exertion during
cardiopulmonary exercise testing
- Active infection including chronic infection
- Active cancer
- Recent (<14 days) use of anti-inflammatory drugs (not including Non-Steroidal
Anti-Inflammatory Drugs [NSAIDs]), Chronic inflammatory disorder (including but not
limited to rheumatoid arthritis, systemic lupus erythematosus), malignancy, or any
comorbidity limiting survival or ability to complete the study
- Pregnancy (determined by urine pregnancy test in women of childbearing potential)
- Inability to give informed consent
- Other conditions limiting completion of cardiopulmonary exercise test or completion
of the study
We found this trial at
1
site
Virginia Commonwealth University Since our founding as a medical school in 1838, Virginia Commonwealth University...
Click here to add this to my saved trials